Arena Pharmaceuticals, Inc. today announced that as of 2021, Arena received an MSCI ESG Rating of "A." "In addition to the Prime status achieved from ISS ESG in May, the MSCI ESG Rating gives us ...

COSMO Pharmaceuticals N.V. ( ($CH:COPN) ) has shared an update. Cosmo Pharmaceuticals has made significant strides in its ESG initiatives, ...

WuXi AppTec, a global company that provides a broad portfolio of R&D and manufacturing services to enable companies in the pharmaceutical and life science industries, today announced it has ...

The MSCI Rating also recognized WuXi AppTec's efforts to ... About WuXi AppTec WuXi AppTec provides a broad portfolio of R&D and manufacturing services that enable companies in the pharmaceutical, ...

MSCI, Inc MSCI closed down 0.82% on Wednesday, capping the day at a per-share price of $413.17 at the end of over 351,000 trades. The stock has seen a turbulent month, as it has mostly (but not ...

MSCI has announced significant changes to its ESG investment fund ratings methodology that “aim to raise the requirements for a fund to be assessed as ‘AA’ or ‘AAA’ rated, improve ...

PARK CITY, Utah--(BUSINESS WIRE)--Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced that as of 2021, Arena received an MSCI ESG Rating of "A." MSCI ESG Research provides MSCI ESG Ratings ...

SHANGHAI, July 7, 2025 /PRNewswire/ -- WuXi AppTec, a global company that provides a broad portfolio of R&D and manufacturing services to enable companies in the pharmaceutical and life science ...

SHANGHAI, July 7, 2025 /PRNewswire/ -- WuXi AppTec, a global company that provides a broad portfolio of R&D and manufacturing services to enable companies in the pharmaceutical and life science ...